Is Biostem Technologies Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Biostem Technologies Inc (BSEM) is currently classified as HALAL as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Biostem Technologies Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Biostem Technologies Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Biostem Technologies Inc?

Muslim investors may consider investing in Biostem Technologies Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Biostem Technologies Inc classified as HALAL?

Musaffa determines the Shariah status of Biostem Technologies Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Biostem Technologies Inc updated?

The Shariah compliance status of Biostem Technologies Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Biostem Technologies Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Biostem Technologies Inc?

You can check the latest Shariah compliance status of Biostem Technologies Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BSEM Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: May 08, 2026

Report Source: 2025 Annual Report

Biostem Technologies Inc. Stock Analysis BSEM

United States Health Care Micro Cap Report: 2025 Annual

BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The firm's products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AMERICAN AMNION. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. The company also owns BioTissue's surgical and wound care business, including the Neox and Clarix product lines.

Key Statistics of Biostem Technologies Inc (BSEM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$4.00$4.53

Today's Open

$4.52

Volume

135.34K

P/E Ratio (TTM)

52 Week Range

$3.09$14.52

Market Cap

71.40M

Avg. Volume

60.32K

Dividend Yield

Financial Metrics & Statements of Biostem Technologies Inc (BSEM)

FAQ's for Biostem Technologies Inc (BSEM)

According to Musaffa’s Shariah screening methodology, Biostem Technologies Inc (BSEM) is currently classified as HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.